Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Share-based Compensation (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Share-based Compensation for 8 consecutive years, with $3485.0 as the latest value for Q1 2025.

  • Quarterly Share-based Compensation fell 61.96% to $3485.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $3485.0 through Dec 2025, down 90.49% year-over-year, with the annual reading at $3485.0 for FY2025, 90.49% down from the prior year.
  • Share-based Compensation for Q1 2025 was $3485.0 at Creative Medical Technology Holdings, down from $9162.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $383612.0 in Q3 2021, with the low at $3485.0 in Q1 2025.
  • Average Share-based Compensation over 5 years is $37795.6, with a median of $9162.0 recorded in 2022.
  • The sharpest move saw Share-based Compensation crashed 97.61% in 2022, then grew 1.1% in 2023.
  • Over 5 years, Share-based Compensation stood at $383612.0 in 2021, then plummeted by 97.61% to $9162.0 in 2022, then changed by 0.0% to $9162.0 in 2023, then changed by 0.0% to $9162.0 in 2024, then tumbled by 61.96% to $3485.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $3485.0, $9162.0, and $9162.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.